With Latisse, you can Grow Eyelashes Long, Dark, full and Sexy  in Just 16 Weeks

Before applying Latisse, remove all eye makeup, washing off any excess oils with soap and water. Apply Latisse to the upper lid only using the sterile, disposable applicators provided with your kit. These applicators are specially designed to hold and release a drop, the precise amount needed for your treatment.

LATISSE^® (bimatoprost ophthalmic solution) 0.03% should only be used once a day at bedtime. Overuse may produce symptoms of eye redness or itchiness.

Staying the full course and using Latisse® as directed is the best way to get the maximum benefit. Here are some tips that may help:

• Incorporate Latisse into your nightly routine to make its use a habit.
• If you accidentally miss a dose, don’t apply an extra amount to catch up. Simply apply the following evening and get back on schedule.
• Avoid touching the tip of the Latisse bottle or applicators with your fingers or other surface to minimize risk of contamination and infection.
• Record your progress, taking pictures of your eyes before you start and at weeks 4, 8, 12 and 16.
• Talk to your practitioner about ongoing maintenance use after your 16 weeks of treatment.

Yes but contact lenses should be removed prior to applying Latisse. Wait 15 minutes before putting contacts back in after using Latisse.

Both men and women who desire an increase in the length, thickness and darkness of the eyelashes may be a candidate for treatment with Latisse. Many men use this product and are happy with their eyelash results.

People who have allergies to bimatoprost or any other ingredient in the product should not use Latisse. People with glaucoma or any eye pressure problems should consult their ophthalmologist before using Latisse. Anyone with an active eye disease or infection and those at risk for eye disorders should consult their physician before using Latisse.

Latisse® is an FDA-approved eyelash growth treatment product that is safe and effective with these potential side effects:

• The most common side effect is itchy and/or red eyes which occurred in 4% of patients in clinical trials.
• Less common side effects are more apt to occur if the solution enters the eyes or makes contact with skin in close proximity to the upper eyelids. These include skin darkening, eye irritation, dryness of the eyes and redness of the eyelids.
• Localized skin darkening of the eyelid occurred in 2.9% of patients but reverses several weeks to months after discontinuing use of Latisse.
• Very infrequently, increased brown iris pigmentation of the colored part of the eye and likely to be permanent has occurred.

Patients are advised to immediately report to their physician or provider, any eye trauma, infection or change in visual acuity and if eye surgery is planned.